Vor Biopharma Inc.
NASDAQ:VOR
Overview | Financials
Company Name | Vor Biopharma Inc. |
Symbol | VOR |
Currency | USD |
Price | 1.34 |
Market Cap | 92,022,624 |
Dividend Yield | 0% |
52-week-range | 0.63 - 2.595 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Robert Ang M.B.A., M.D., MBBS |
Website | https://www.vorbio.com |
An error occurred while fetching data.
About Vor Biopharma Inc.
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD